• Login
No Result
View All Result
Gujarat Journal
  • Home
  • Gujarat News
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
  • Home
  • Gujarat News
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
No Result
View All Result
Gujarat Journal
No Result
View All Result
Home Lifestyle Health & Fitness

AustralaSian COVID-19 Trial opens in India

by Gujarat Journal Team
March 1, 2021
in Health & Fitness, National
Reading Time: 2 mins read
A A
0
Share on FacebookShare on Twitter

New Delhi: AustralaSian COVID-19 Trial (ASCOT) has been expanded into India, with the first patients recruited last week to the first two sites, Christian Medical College and Hospital Ludhiana in Punjab and Sterling Multispecialty Hospital in Pune, Maharashtra. Australasia is a region that comprises Australia, New Zealand, and some neighboring islands.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.George Institute for Global Health is an independent medical research institute headquartered in Australia with offices in China, India and the United Kingdom.

You May AlsoLike This

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

September 30, 2023
KareXpert achieves Ayushman Bharat Digital Mission Certification, paving the way for the digital healthcare revolution

KareXpert achieves Ayushman Bharat Digital Mission Certification, paving the way for the digital healthcare revolution

September 13, 2023

“Empowering Women Through Innovative Healthcare: Dr. Monika Agarwal, Leading Cosmetic Gynaecologist and Laparoscopic Surgeon in Ghaziabad”

September 4, 2023

MedscapeIndia takes initiative to protect doctors through a ‘Health Tribunal Law’

August 18, 2023

ASCOT aims to discover which existing treatments are most effective in patients hospitalised with COVID-19 and whether they will prevent patients deteriorating to the point of needing a ventilator in the Intensive Care Unit.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.

ASCOT Principal Investigator, Associate Professor Steven Tong, a Royal Melbourne Hospital infectious diseases clinician and co-lead of clinical research at the Doherty Institute said that while ASCOT began as an Australian and New Zealand trial, expanding internationally to allow more widespread access to investigational treatments was crucial.

“A key principle of the trial is equity in terms of access to experimental treatments that could potentially have benefits for patients,” Associate Professor Tong said.

“The ASCOT Management Team and Leadership Group recognised early in the course of the trial that for it to have generalisability, external validity and be adequately powered, it would need to be expanded to international sites.”

India, like many other middle and low-income countries, is facing a severe epidemic of COVID-19. The number of patients with COVID-19 in India remains significantly higher than in Australia and New Zealand, and access to experimental treatments is limited.

Bala Venkatesh, Professorial Fellow at the George Institute for Global Health, said that while there are other ongoing clinical trials in India for COVID-19, the novel combinations of treatments included in ASCOT will provide greater opportunities to patients for accessing new treatments.

“We are confident that the study questions being asked are of priority to Indian patients and participating trial sites, and feasible to address in India,” said Professor Venkatesh.

One new treatment that’s recently been added to ASCOT is Nafamostat, which in laboratory experiments has shown to block SARS-COV-2 from entering human cells and be far more potent than Remdesivir.

“Nafamostat is mainly used in Korea and Japan as a treatment for acute pancreatitis and some blood clotting conditions. Of all drugs with potency data from laboratory studies using human cell lines, nafamostat appears to be the most potent against SARS-CoV-2 and maybe the only drug where blood concentrations almost always exceed levels required to stop the virus from replicating,” explained Associate Professor Tong.

“It is also likely that Nafamostat will reach high levels in the lungs where the SARS-CoV-2 virus causes so much of its problems. What’s more, it has a favourable safety profile.”

The ASCOT Steering Committee recently made the decision to cease enrolment into the convalescent plasma arm of the trial following a media release issued by the UK’s RECOVERY trial, which reported no benefit to patients compared with standard of care. (India Science Wire)

Tags: ASCOTAustralaSianChristian Medical College and HospitalClinical TrialCOVID-19Sterling Multispecialty Hospital
ShareTweetShareSendShareShareSendPin
Previous Post

Dr. Harsh Vardhan dedicates two new databases to the nation

Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

Related Posts

Narayana Health launches their First Ever Brand Campaign ‘Take Care’
Health & Fitness

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

September 30, 2023
KareXpert achieves Ayushman Bharat Digital Mission Certification, paving the way for the digital healthcare revolution
Health & Fitness

KareXpert achieves Ayushman Bharat Digital Mission Certification, paving the way for the digital healthcare revolution

September 13, 2023
“Empowering Women Through Innovative Healthcare: Dr. Monika Agarwal, Leading Cosmetic Gynaecologist and Laparoscopic Surgeon in Ghaziabad”
Health & Fitness

“Empowering Women Through Innovative Healthcare: Dr. Monika Agarwal, Leading Cosmetic Gynaecologist and Laparoscopic Surgeon in Ghaziabad”

September 4, 2023
MedscapeIndia takes initiative to protect doctors through a ‘Health Tribunal Law’
Health & Fitness

MedscapeIndia takes initiative to protect doctors through a ‘Health Tribunal Law’

August 18, 2023
A Coworker’s Heroic CPR and AED Deployment Saves a 52-Year-Old Man from Cardiac Arrest
Health & Fitness

A Coworker’s Heroic CPR and AED Deployment Saves a 52-Year-Old Man from Cardiac Arrest

August 8, 2023
Use of Artificial Intelligence (AI) in Angioplasty, Dr. Ankur Phatarpekar announces the integration of the latest OCT
Health & Fitness

Use of Artificial Intelligence (AI) in Angioplasty, Dr. Ankur Phatarpekar announces the integration of the latest OCT

July 26, 2023

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Seema Kalavadia's Style Symphony: Ahmedabad Times Fashion Week 2023

Seema Kalavadia’s Style Symphony: Ahmedabad Times Fashion Week 2023

12 hours ago
Vision11: Gaming Without GST Hassles: Play and Let Vision Pay the 28% GST

Vision11: Gaming Without GST Hassles: Play and Let Vision Pay the 28% GST

15 hours ago

Trending

Ooka AUDiO: A Game-Changer in the World of Audio Technology

Ooka AUDiO: A Game-Changer in the World of Audio Technology

4 days ago
Narayana Health launches their First Ever Brand Campaign ‘Take Care’

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

4 days ago

Popular

Orika Spices Unveils a New Era of Culinary Excellence with the Launch of its Premium Whole Spices Range

Orika Spices Unveils a New Era of Culinary Excellence with the Launch of its Premium Whole Spices Range

4 weeks ago
The Moms Co Mompreneurs Show Welcomes Exciting and Powerful New Partnerships to support Mom-Entrepreneurs

The Moms Co Mompreneurs Show Welcomes Exciting and Powerful New Partnerships to support Mom-Entrepreneurs

3 weeks ago
Ooka AUDiO: A Game-Changer in the World of Audio Technology

Ooka AUDiO: A Game-Changer in the World of Audio Technology

4 days ago
Graphikians Presents “Brain Show”: A Path to Empower Students and Schools Worldwide

Graphikians Presents “Brain Show”: A Path to Empower Students and Schools Worldwide

4 weeks ago
Juhu: Mumbai’s Luxury Residential Haven for India’s Crème De La Crème

Juhu: Mumbai’s Luxury Residential Haven for India’s Crème De La Crème

3 weeks ago

Gujarat Journal, digital news and story platform bring you the news, articles, stories, and opinions on the latest happenings worldwide covering various sectors like nation, politics, and governance, social sector, review, foreign affairs, defence and security, latest review, lifestyle, entertainment, sports, technology, auto sectors, education, business and start-ups updates, Agriculture, Science, finance, money, food, and culture, etc.

Category

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Gujarat News
  • Health & Fitness
  • India
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • Uncategorized
  • World

Follow Us

  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

Copyright © 2022 Gujarat Journal

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

Copyright © 2022 Gujarat Journal

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In